Pharmacological assessments of polyphenolic extract of Cymbopogon citratus leaves in rodent model of parkinson’s disease
Parkinson's disease (PD) is amongst the most common age-related neurodegenerative disorders. Natural compounds, especially the polyphenols have gained great interest as potential therapeutic agents in recent research. Thus, the present study was designed to evaluate the effect of polyphenolic extract of Cymbopogon citratus (C. Citratus) leaves in animal models of PD. In the given study PD was induced by administration of reserpine (5 mg/kg/day, i.p for 5 consecutive days), haloperidol (1 mg/kg, i.p.), in experimental animals. The symptoms of PD such as tremors, akinesia, rigidity and catalepsy were evaluated. Ethanolic extract of Cymbopogon citratus (CC) in doses of 100, 200 & 400mg/kg were administered per oral (PO). The L-dopa and carbidopa (30 mg/kg, PO) combination was used as a positive standard drug. Behavioural studies such as locomotor activity were performed. In catalepsy model, there is significant reduction in catalepsy duration in CC (100, 200, 400mg/kg) treated group as compared to the haloperidol group. In reserpine model, there is significant decrease of muscular rigidity, tremors, and akinesia in groups treated with CC (100, 200, 400mg/kg) dose dependently. Thus, the present study suggests the beneficial role of C. citratus leaves polyphenolic extract in treatment of parkinsonian like symptoms.
Keywords: Parkinson’s disease; catalepsy test; haloperidol; reserpine, rotarod test, polyphenols, Cymbopogon citratus
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).